Elif Özbay
Elif Özbay earned a B.Sc. degree in Molecular Biology and Genetics from Istanbul Arel University and her M.Sc. and Ph.D. degrees in Neuroscience at Istanbul Medipol University. Her research focused on the proteomic analysis of circadian rhythms following brain injury. Her areas of expertise include biomarker discovery using mass spectrometry–based shotgun, bottom-up, label-free, and DIA proteomics methods. She is currently working as a senior researcher in the Proteomics Department of the Systems Biology Laboratory at SABİTA and is a team member of MODAS at Istanbul Medipol University.Selected Publications;
Phosphodiesterase 10A Is a Critical Target for Neuroprotection in a Mouse Model of Ischemic Stroke
Beker MC, Caglayan AB, Altunay S, Ozbay E, Ates N, Kelestemur T, Caglayan B, Kilic U, Doeppner TR, Hermann DM, Kilic E. Phosphodiesterase 10A Is a Critical Target for Neuroprotection in a Mouse Model of Ischemic Stroke. Mol Neurobiol. 2022 Jan;59(1):574-589. doi: 10.1007/s12035-021-02621-5. Epub 2021 Nov 4. PMID: 34735672.
Circadian clock protein Bmal1 protects against transient focal cerebral ischemia in mice by regulating master signals controlling cell survival and metabolism
Experimental Neurology, Volume 395, 2026, 115481, ISSN 0014-4886, https://doi.org/10.1016/j.expneurol.2025.115481.
An analysis for proteomic profile of NeuroD2 related changes in N2A neuroblastoma cell line
Ann Med Res [Internet]. 2023 Jan. 21 [cited 2025 Jul. 22];30(1):21-5.
Phosphodiesterase 10A is a critical target for neuroprotection in a mouse model of ischemic stroke
Beker, M.C., Caglayan, A.B., Altunay, S. et al. Mol Neurobiol 59, 574–589 (2022). https://doi.org/10.1007/s12035-021-02621-5